Single Cell Proteomics Landscape 2026 — PatSnap Eureka
Single-Cell Proteomics Technology Landscape 2026
From proof-of-concept to routine quantification of 1,000–3,000 protein groups per mammalian cell — map the five technical pillars, key innovators, and emerging directions shaping scp-MS with PatSnap Eureka.
Why Single-Cell Proteomics Demands a New Technical Paradigm
Single-cell proteomics by mass spectrometry (scp-MS) addresses a fundamental limitation of conventional proteomics: bulk samples comprising thousands or millions of cells yield only population averages, obscuring critical cellular heterogeneity in development, disease, and drug response. Unlike genomics and transcriptomics, proteins cannot be amplified, making sensitivity the defining technical challenge.
The field has progressed from proof-of-concept demonstrations to routine quantification of more than 1,000–3,000 protein groups per single mammalian cell. This has been achieved through five interconnected technical pillars: miniaturized and automated sample preparation, ultra-low-flow chromatographic separations, ion mobility spectrometry integration, next-generation MS acquisition strategies (DDA, DIA, WWA), and AI-driven spectral library-based data analysis.
According to a comprehensive review from the Technical University of Denmark, scp-MS has moved beyond technical demonstration into genuine biological application — covering oncology, developmental biology, immunology, and spatial biology. Teams using PatSnap's life sciences intelligence platform can map this entire landscape from a single interface.
The innovation dataset spanning 2013–2023 reveals a clear three-phase trajectory: a foundational phase (2007–2015) establishing feasibility, a development phase (2018–2021) converging critical workflow innovations, and a scale-up and maturation phase (2022–2023) pivoting from sensitivity to throughput, automation, and clinical application.
Four Workflow Innovation Clusters Defining scp-MS
Each cluster addresses a distinct bottleneck in the single-cell proteomics pipeline, from sample handling through to data interpretation.
Nanodroplet & Miniaturized Sample Preparation
The dominant bottleneck in scp-MS is protein loss during sample handling. The nanoPOTS paradigm confines lysis, reduction, alkylation, and digestion to sub-microliter volumes. Combined with wide window acquisition (WWA), nanoPOTS achieved more than 3,000 proteins from single cells in label-free analyses. Academia Sinica's iProChip achieved 1,160 protein groups via DIA-MS; the IMP Vienna one-pot workflow identified 1,790 proteins per cell in 384-well plates compatible with semi-automated CellenONE dispensing.
>3,000 proteins · nanoPOTS + WWAIon Mobility Spectrometry Integration
FAIMS and TIMS add a fourth separation dimension alongside retention time, mass, and charge — reducing chemical noise and enabling longer ion accumulation for trace signals. Brigham Young University's TIFF method achieved more than 1,700 proteins per HeLa cell using 3D MS1 feature matching. The Technical University of Munich's timsTOF approach robustly quantified more than 430 single-cell proteomes from FACS-isolated cells, demonstrating cell cycle state prediction and perturbation response tracking.
>1,700 proteins · TIFF (BYU)Advanced MS Acquisition Strategies (DDA, DIA, WWA)
DDA, DIA, and WWA represent distinct philosophies for sampling the proteome from minimal input. DIA offers reproducibility advantages critical at single-cell input. WWA deliberately co-isolates multiple precursors to improve coverage; combined with the AI-based CHIMERYS search engine and micro pillar array columns (µPAC), it boosted peptide identification by 140% over classical packed-bed columns. The IceR framework addresses the endemic missing-value problem in DDA-based scp-MS using ion current information for hybrid peptide identification propagation.
140% peptide ID boost · WWA + CHIMERYSMultiplexed Isobaric Labeling & Carrier Proteome Strategies
Isobaric labeling (TMT, SCoPE-MS) enables multiplexed analysis of many single cells within a single MS run by incorporating a carrier channel of boosted material to elevate total signal. Shanghai Jiao Tong University's UE-SCP workflow coupled isobaric labeling with timsTOF MS, achieving quantification depth of more than 1,000 proteins per cell without specialized microfluidics. Baylor College of Medicine's SLB-SCP platform leveraged physicochemical characteristics encoded in spectral libraries to extract maximal information from inherently low MS/MS signals.
>1,000 proteins · UE-SCP (SJTU)Protein Detection Depth & Geographic Innovation Distribution
Key quantitative benchmarks from the scp-MS literature dataset, analyzed via PatSnap Eureka across 28 publications (2013–2023).
Protein Groups Detected Per Single Cell by Workflow
nanoPOTS + WWA leads with 3,000+ protein groups; IMP Vienna one-pot workflow identifies 1,790; TIFF (BYU) achieves 1,700+.
Geographic Distribution of scp-MS Innovation (2013–2023)
The US leads in total institutional contributions; China is the fastest-growing emerging geography in the dataset, with multiple high-impact workflow innovations.
Where Single-Cell Proteomics Is Driving Biological Discovery
Four major application clusters emerge from the retrieved literature dataset, each representing a distinct translational opportunity for scp-MS technology.
Oncology & Tumor Microenvironment
The largest application cluster in the dataset. Massachusetts General Hospital's i2SCAN system combined cyclic antibody panels with computational analysis for deep profiling of breast cancer fine needle aspirates within a single day. The Tumor Profiler Study (University Hospital Zurich) integrated scp-MS proteotyping with CyTOF and single-cell genomics across melanoma, ovarian carcinoma, and acute myeloid leukemia. Multi-omics platforms including CyTOF and imaging mass cytometry (Hyperion, CODEX) are reviewed as enabling tools for hematopoiesis and autoimmunity research by the University of Pittsburgh.
Tumor Profiler Study · Melanoma · AML · Ovarian CarcinomaDevelopmental Biology & Cell State Characterization
Single-cell multi-omics approaches are enabling simultaneous transcriptome and proteome profiling during developmental transitions. Zhejiang University's scSTAP platform achieved concurrent quantification of 19,948 genes and 2,663 protein groups in single mouse oocytes across meiotic maturation stages — a landmark demonstration of multi-modal single-cell capture. Cell cycle state prediction and perturbation response tracking have also been demonstrated using single-cell timsTOF workflows from the Technical University of Munich.
19,948 genes + 2,663 proteins · scSTAP · Single oocyteImmunology & Immune Cell Profiling
Microchip-based functional proteomics platforms from the California Institute of Technology provided early demonstrations of single-cell phosphoprotein signaling network analysis in immune cells and cancer as early as 2013. The University of Queensland generated a primary human T-cell spectral library covering 4,833 distinct proteins to support DIA-based quantitative single-cell proteomics of immune subsets — a foundational resource enabling large-scale T-cell proteomics studies. These resources underpin life sciences R&D intelligence workflows.
4,833 T-cell proteins · DIA spectral library · U. QueenslandSpatial Biology & Tissue Proteomics
Spatially resolved MS approaches including mass spectrometry imaging (MSI) and reporter-based heavy metal tagging enable subcellular localization of proteins within tissue sections. Pacific Northwest National Laboratory reviewed multiple spatially resolved MS techniques for single-cell proteomics and metabolomics, highlighting progress in MSI for characterizing heterogeneous tissue populations. This spatial dimension adds a critical layer of biological context beyond what cell suspension-based scp-MS can provide. Explore PatSnap's patent landscape analytics for spatial proteomics IP.
MSI · Spatial MS · PNNL · Subcellular localizationFour Strategic Frontiers Shaping the Next Phase of scp-MS
The most recent results in the dataset (2022–2023) signal a clear pivot from sensitivity to throughput, automation, and multi-modal integration.
Next-Generation MS Analyzers
The 2023 benchmarking of the Orbitrap Astral analyzer — combining a conventional Orbitrap with a novel Asymmetric Track Lossless (Astral) high-resolution accurate mass analyzer — by the Technical University of Denmark signals a step-change in acquisition speed and sensitivity directly targeted at single-cell throughput constraints. This represents the most recent dated result in the dataset and a strong signal of the instrument frontier.
Single-Cell Multi-Omics Integration
The simultaneous capture of transcriptome and proteome from a single cell — exemplified by Zhejiang University's scSTAP platform quantifying 19,948 genes and 2,663 protein groups in single mouse oocytes — is rapidly gaining traction as the natural successor to single-modality approaches. Mozhuo Biotech's review of single-cell technologies from research to application (2022) reflects commercial interest in this convergence.
IP Strategy & Competitive Intelligence Priorities for scp-MS
Five strategic signals from the landscape dataset that should inform R&D investment, IP portfolio strategy, and competitive monitoring decisions.
| Strategic Priority | Key Signal from Dataset | Action Implication |
|---|---|---|
| Instrument Platform Choice | timsTOF (Bruker) and Orbitrap Astral (Thermo Fisher) represent divergent but equally compelling platform bets for scp-MS | Monitor both Bruker and Thermo Fisher Scientific filing activity closely — instrument-method co-innovation is the defining dynamic |
| Sample Preparation IP Whitespace | Miniaturized and automated sample preparation (nanoPOTS, iProChip, CellenONE-compatible protocols) consistently emerges as the rate-limiting step | Workflow IP around cell lysis, nanodroplet handling, and automated protein cleanup represents significant whitespace opportunity |
| Multi-Omics Integration | Convergence of scp with transcriptomics (scSTAP, CITE-seq analogues) is accelerating — Zhejiang University demonstrated 19,948 genes + 2,663 proteins simultaneously | Organizations investing early in simultaneous multi-modal single-cell capture for clinical specimens will be positioned at the intersection of two high-growth markets |
| China Jurisdiction Monitoring | Multiple high-impact scp-MS workflow innovations originate from Chinese academic institutions and Mozhuo Biotech (Zhejiang) | IP strategists should audit freedom-to-operate and filing coverage in CN jurisdiction specifically for sample preparation and chip-based workflows |
| Clinical Translation Window | Multiple results link scp-MS directly to tumor microenvironment analysis, liquid biopsy, and clinical decision support | Transition from research tool to clinical assay requires standardized community protocols and regulatory engagement — no single actor has yet established this, creating an open window |
Map the Full scp-MS Competitive Landscape
PatSnap Eureka combines patent data, literature, and AI analysis to surface the signals that matter for your R&D strategy. Trusted by leading life sciences organizations globally.
Who Is Driving Single-Cell Proteomics Innovation?
Innovation in scp-MS is distributed across a relatively small number of highly active academic and industrial nodes, with no single commercial assignee dominating the core technology space. The United States is the most represented jurisdiction in this dataset, with key contributions from Brigham Young University (ion mobility filtering, TIFF method), Northeastern University (scaling and parallelization), Baylor College of Medicine (SLB-SCP), Johns Hopkins University (single-cell protein copy number metrics), Pacific Northwest National Laboratory (spatial MS), and the California Institute of Technology (microchip platforms).
Germany is the most prominent European contributor: the Technical University of Munich (timsTOF single-cell workflows), the German Cancer Research Center (IceR), and the Gregor Mendel Institute/Austrian Academy of Sciences (WWA + AI data analysis) drive innovation in instrumentation-coupled workflows. The European Patent Office represents a key filing jurisdiction for these groups.
China represents the fastest-growing emerging geography in the dataset: Shanghai Jiao Tong University (UE-SCP multiplexed SCP), Zhejiang University (scSTAP multi-omics), Academia Sinica (iProChip-DIA), and Mozhuo Biotech (Zhejiang) reflect diversified investments from academic and commercial actors alike. IP strategists should audit freedom-to-operate and filing coverage in the CN jurisdiction specifically for sample preparation and chip-based workflows.
On the commercial instrument side, Thermo Fisher Scientific is the only major instrument vendor explicitly named as an assignee in core scp-MS results, contributing the FAIMS-coupled ultrasensitive workflow. The broader instrument ecosystem (timsTOF by Bruker, Orbitrap platforms) is referenced extensively in results attributed to academic groups. Access PatSnap's IP analytics platform to track assignee-level filing activity across all jurisdictions.
Single-Cell Proteomics — key questions answered
Single-cell proteomics (SCP) enables protein-level characterization of individual cells to reveal biological heterogeneity that bulk population measurements systematically obscure. Unlike genomics and transcriptomics, proteins cannot be amplified, making sensitivity the defining technical challenge. The field has progressed from proof-of-concept demonstrations to routine quantification of more than 1,000–3,000 protein groups per single mammalian cell.
The field is defined by five interconnected technical pillars: (1) miniaturized and automated sample preparation to minimize protein loss from nanogram-level inputs; (2) ultra-low-flow and advanced chromatographic separations to maximize peptide detection; (3) ion mobility spectrometry integration to reduce chemical noise and extend ion accumulation; (4) next-generation MS acquisition strategies (DDA, DIA, WWA) for comprehensive and reproducible protein identification; and (5) AI-driven and spectral library-based data analysis to overcome missing value problems and boost identification rates.
Current workflows routinely quantify more than 1,000–3,000 protein groups per single mammalian cell. Specific benchmarks include: the Thermo Fisher Scientific ultrasensitive workflow identifying more than 1,000 protein groups per mammalian cell; the nanoPOTS combined with wide window acquisition (WWA) achieving more than 3,000 proteins from single cells in label-free analyses; and Academia Sinica's iProChip achieving 1,160 protein groups from a single mammalian cell via DIA-MS.
Innovation in scp-MS is distributed across a relatively small number of highly active academic and industrial nodes. In the United States: Brigham Young University (ion mobility filtering, TIFF method), Northeastern University (scaling and parallelization), Baylor College of Medicine (SLB-SCP), and California Institute of Technology (microchip platforms). In Germany: Technical University of Munich (timsTOF workflows) and German Cancer Research Center (IceR). In China: Shanghai Jiao Tong University (UE-SCP), Zhejiang University (scSTAP multi-omics), and Academia Sinica (iProChip-DIA). Thermo Fisher Scientific is the only major instrument vendor explicitly named as an assignee in core scp-MS results.
Four distinct emerging directions are identifiable from the most recent results: (1) Next-generation MS analyzers — the 2023 benchmarking of the Orbitrap Astral analyzer signals a step-change in acquisition speed and sensitivity; (2) Single-cell multi-omics integration — simultaneous capture of transcriptome and proteome from a single cell, exemplified by Zhejiang University's scSTAP platform; (3) Automation and democratization — standardized, semi-automated 384-well workflows using commercial cell dispensers (CellenONE) designed for adoption beyond specialist laboratories; (4) AI and spectral library-driven analysis — integration of AI-based search engines (CHIMERYS) and spectral library matching to overcome identification bottlenecks at ultra-low input.
Ion mobility spectrometry (IMS) — particularly high-field asymmetric ion mobility spectrometry (FAIMS) and trapped ion mobility spectrometry (TIMS) — adds a fourth separation dimension (alongside retention time, mass, and charge), reducing chemical noise and enabling longer ion accumulation for trace signals. Brigham Young University's TIFF method achieved more than 1,700 proteins per HeLa cell using 3D MS1 feature matching across retention time, accurate mass, and FAIMS compensation voltage. The Technical University of Munich's timsTOF-based approach robustly quantified more than 430 single-cell proteomes from FACS-isolated cells.
Still have questions? Let PatSnap Eureka search the scp-MS patent and literature database for you.
Ask PatSnap Eureka Your SCP QuestionAccelerate Your Single-Cell Proteomics R&D Strategy
Join 18,000+ innovators already using PatSnap Eureka to map technology landscapes, identify IP whitespace, and monitor competitors across life sciences.
References
- Single-cell Proteomics: Progress and Prospects — Brigham Young University, 2020, USA
- Recent advances in the field of single-cell proteomics — Technical University of Denmark, 2023, Denmark
- Ultrasensitive single-cell proteomics workflow identifies >1000 protein groups per mammalian cell — Thermo Fisher Scientific, 2021, USA
- Ultra-high sensitivity mass spectrometry quantifies single-cell proteome changes upon perturbation — Technical University of Munich, 2022, Germany
- Scaling Up Single-Cell Proteomics — Northeastern University, 2022, USA
- Three-dimensional feature matching improves coverage for single-cell proteomics based on ion mobility filtering — Brigham Young University, 2022, USA
- Ultra-streamlined single cell proteomics by all-in-one chip and data-independent-acquisition mass spectrometry — Academia Sinica, 2021, Taiwan
- An ultra-sensitive and easy-to-use multiplexed single-cell proteomic analysis — Shanghai Jiao Tong University, 2022, China
- Spectral Library-Based Single-Cell Proteomics Resolves Cellular Heterogeneity — Baylor College of Medicine, 2022, USA
- Evaluating the capabilities of the Astral mass analyzer for single-cell proteomics — Technical University of Denmark, 2023, Denmark
- Wide Window Acquisition and AI-based data analysis to reach deep proteome coverage for a wide sample range, including single cell proteomic inputs — Gregor Mendel Institute / Austrian Academy of Sciences, 2022, Austria
- IceR improves proteome coverage and data completeness in global and single-cell proteomics — German Cancer Research Center, 2021, Germany
- Data-Dependent Acquisition with Precursor Coisolation Improves Proteome Coverage and Measurement Throughput for Label-Free Single-Cell Proteomics — 2022, USA
- Optimized Data-Independent Acquisition Approach for Proteomic Analysis at Single-Cell Level — 2021
- Robust and easy-to-use one pot workflow for label free single cell proteomics — Institute of Molecular Pathology (IMP), Vienna, 2022, Austria
- Single-Cell Proteomics: The Critical Role of Nanotechnology — University of Salamanca, 2022, Spain
- Simultaneous transcriptome and proteome profiling in a single mouse oocyte with a deep single-cell multi-omics approach — Zhejiang University, 2022, China
- Spatially Resolved Mass Spectrometry at the Single Cell: Recent Innovations in Proteomics and Metabolomics — Pacific Northwest National Laboratory, 2021, USA
- Microchip platforms for multiplex single-cell functional proteomics with applications to immunology and cancer research — California Institute of Technology, 2013, USA
- The Tumor Profiler Study: Integrated, multi-omic, functional tumor profiling for clinical decision support — University Hospital Zurich, 2020, Switzerland
- Integrated Analytical System for Clinical Single-Cell Analysis — Massachusetts General Hospital, 2022, USA
- High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery — University of Pittsburgh Medical Center, 2021, USA
- A primary human T-cell spectral library to facilitate large scale quantitative T-cell proteomics — University of Queensland, 2020, Australia
- Single-cell technologies: From research to application — Mozhuo Biotech (Zhejiang) Co., Ltd., 2022, China
- Accelerating a paradigm shift: The Common Fund Single Cell Analysis Program — NIH, 2018, USA
- Evaluation of the Sensitivity of Proteomics Methods Using the Absolute Copy Number of Proteins in a Single Cell as a Metric — Johns Hopkins University, 2021, USA
- NIH National Institutes of Health — Single Cell Analysis Program
- European Patent Office — Biotechnology Patent Filings
- Technical University of Denmark — Proteomics Research
- University of Pittsburgh — Multi-Omics Drug Discovery Research
All data and statistics on this page are sourced from the references above and from PatSnap's proprietary innovation intelligence platform. This landscape is derived from a targeted set of patent and literature records and represents a snapshot of innovation signals within this dataset only — it should not be interpreted as a comprehensive view of the full industry.
PatSnap Eureka searches patents and research to answer instantly.